These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 19396721)

  • 21. [Recent evolution and characterization of extended-spectrum beta-lactamase producing enterobacteria in the CHU of Nice (2005-2007)].
    Giraud-Morin C; Fosse T
    Pathol Biol (Paris); 2008; 56(7-8):417-23. PubMed ID: 18848404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CTX-M-1-related extended-spectrum beta-lactamases producing Escherichia coli: so far a sporadic event in Western Austria.
    Prelog M; Fille M; Prodinger W; Grif K; Brunner A; Würzner R; Zimmerhackl LB
    Infection; 2008 Aug; 36(4):362-7. PubMed ID: 18574554
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prevalence and types of extended-spectrum beta-lactamases among urinary Escherichia coli and Klebsiella spp. in New Zealand.
    Heffernan HM; Woodhouse RE; Pope CE; Blackmore TK
    Int J Antimicrob Agents; 2009 Dec; 34(6):544-9. PubMed ID: 19748232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epidemiological investigation of fluoroquinolone resistance in infections due to extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae.
    Lautenbach E; Strom BL; Bilker WB; Patel JB; Edelstein PH; Fishman NO
    Clin Infect Dis; 2001 Oct; 33(8):1288-94. PubMed ID: 11565067
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.
    Rooney PJ; O'Leary MC; Loughrey AC; McCalmont M; Smyth B; Donaghy P; Badri M; Woodford N; Karisik E; Livermore DM
    J Antimicrob Chemother; 2009 Sep; 64(3):635-41. PubMed ID: 19549667
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes.
    Lautenbach E; Patel JB; Bilker WB; Edelstein PH; Fishman NO
    Clin Infect Dis; 2001 Apr; 32(8):1162-71. PubMed ID: 11283805
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The prevalence of ESBL-producing E. coli and Klebsiella strains in the Copenhagen area of Denmark.
    Kjerulf A; Hansen DS; Sandvang D; Hansen F; Frimodt-Møller N
    APMIS; 2008 Feb; 116(2):118-24. PubMed ID: 18321362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Virulence genotype and nematode-killing properties of extra-intestinal Escherichia coli producing CTX-M beta-lactamases.
    Lavigne JP; Blanc-Potard AB; Bourg G; Moreau J; Chanal C; Bouziges N; O'callaghan D; Sotto A
    Clin Microbiol Infect; 2006 Dec; 12(12):1199-206. PubMed ID: 17121626
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CTX-M-15-producing multidrug-resistant enteroaggregative Escherichia coli in the United Arab Emirates.
    Sonnevend A; Al Dhaheri K; Mag T; Herpay M; Kolodziejek J; Nowotny N; Usmani A; Sheikh FA; Pál T
    Clin Microbiol Infect; 2006 Jun; 12(6):582-5. PubMed ID: 16700710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevalence of extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care hospital in Tehran, Iran.
    Mehrgan H; Rahbar M
    Int J Antimicrob Agents; 2008 Feb; 31(2):147-51. PubMed ID: 18060745
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum beta-lactamases.
    Romero L; López L; Rodríguez-Baño J; Ramón Hernández J; Martínez-Martínez L; Pascual A
    Clin Microbiol Infect; 2005 Aug; 11(8):625-31. PubMed ID: 16008614
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in Spanish hospitals: 2nd multicenter study (GEIH-BLEE project, 2006)].
    Angel Díaz M; Ramón Hernández J; Martínez-Martínez L; Rodríguez-Baño J; Pascual A;
    Enferm Infecc Microbiol Clin; 2009 Nov; 27(9):503-10. PubMed ID: 19329230
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Change in the prevalence of extended-spectrum-beta-lactamase-producing Escherichia coli in Japan by clonal spread.
    Suzuki S; Shibata N; Yamane K; Wachino J; Ito K; Arakawa Y
    J Antimicrob Chemother; 2009 Jan; 63(1):72-9. PubMed ID: 19004839
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular characterization of CTX-M-15-producing clinical isolates of Escherichia coli reveals the spread of multidrug-resistant ST131 (O25:H4) and ST964 (O102:H6) strains in Norway.
    Naseer U; Haldorsen B; Tofteland S; Hegstad K; Scheutz F; Simonsen GS; Sundsfjord A;
    APMIS; 2009 Jul; 117(7):526-36. PubMed ID: 19594493
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The first occurrence of a CTX-M ESBL-producing Escherichia coli outbreak mediated by mother to neonate transmission in an Irish neonatal intensive care unit.
    O'Connor C; Philip RK; Kelleher J; Powell J; O'Gorman A; Slevin B; Woodford N; Turton JF; McGrath E; Finnegan C; Power L; O'Connell NH; Dunne CP
    BMC Infect Dis; 2017 Jan; 17(1):16. PubMed ID: 28056822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of phenotype and genotype on methods for detection of extended-spectrum-beta-lactamase-producing clinical isolates of Escherichia coli and Klebsiella pneumoniae in Norway.
    Tofteland S; Haldorsen B; Dahl KH; Simonsen GS; Steinbakk M; Walsh TR; Sundsfjord A;
    J Clin Microbiol; 2007 Jan; 45(1):199-205. PubMed ID: 17079502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevalence of extended-spectrum beta-lactamase and class 1 integron integrase gene intl1 in Escherichia coli from Thai patients and healthy adults.
    Pongpech P; Naenna P; Taipobsakul Y; Tribuddharat C; Srifuengfung S
    Southeast Asian J Trop Med Public Health; 2008 May; 39(3):425-33. PubMed ID: 18564681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nosocomial outbreak of CTX-M-15-producing E. coli in Norway.
    Naseer U; Natås OB; Haldorsen BC; Bue B; Grundt H; Walsh TR; Sundsfjord A
    APMIS; 2007 Feb; 115(2):120-6. PubMed ID: 17295678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk-factors for emerging bloodstream infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Rodríguez-Baño J; Navarro MD; Romero L; Muniain MA; Cueto Md; Gálvez J; Perea EJ; Pascual A
    Clin Microbiol Infect; 2008 Feb; 14(2):180-3. PubMed ID: 18005358
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Extended-spectrum beta-lactamase (ESBL) CTX-M-15-producing Escherichia coli and Klebsiella pneumoniae in Sofia, Bulgaria.
    Markovska R; Schneider I; Keuleyan E; Bauernfeind A
    Clin Microbiol Infect; 2004 Aug; 10(8):752-5. PubMed ID: 15301679
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.